Pharma Focus Asia

Colorcon Plans to Build a New Starch Manufacturing Unit


Colorcon announced its plans to build a new starch manufacturing unit in Amsterdam, Netherlands.


This new facility is planned to double the existing manufacturing capacity for Starch 1500®, Pregelatinised Maize Starch, supporting the continued growth of Colorcon’s excipient business across the world.

The plant will provide a secure second source of supply with the same quality, consistency and equivalency to the product manufactured in our existing facility.

New plant is located in the heart of Europe near the port Rotterdam; the facility will produce GMP starch products for the pharmaceutical and nutritional markets.

The facility is expected to be operational by 2022.


ScheduleScheduled to be operational by 2022
magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference